Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing

Bibliographic Details
Title: Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing
Authors: Li, Li, Deng, Lan, Meng, Xiaoqing, Gu, Changling, Meng, Li, Li, Kai, Zhang, Xuesai, Meng, Yun, Xu, Wei, Zhao, Le, Chen, Jianhe, Zhu, Zhenping, Huang, Haomin
Source: In Translational Oncology January 2021 14(1)
Database: ScienceDirect
More Details
ISSN:19365233
DOI:10.1016/j.tranon.2020.100916
Published in:Translational Oncology
Language:English